Michael D. Levitt

机构：Hackensack Meridian Health · ORCID：0000-0001-9124-0971

发表论文 135 篇 · 总被引 4358 次 · h-index 30

代表论文

• Adverse Effects of Immune Checkpoint Inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): Results of a Retrospective Study (2019 · Journal of Clinical Medicine Research · 被引 180)
• Saccharomyces cerevisiae fungemia in a critically ill patient with acute cholangitis and long term probiotic use (2018 · Medical Mycology Case Reports · 被引 45)
• The feasibility and safety of early ileostomy reversal: a systematic review and meta‐analysis (2020 · ANZ Journal of Surgery · 被引 33)
• Erythrocyte aging as a mechanism of anemia and a biomarker of device thrombosis in continuous-flow left ventricular assist devices (2017 · The Journal of Heart and Lung Transplantation · 被引 22)
• Dabigatran-Induced Acute Interstitial Nephritis: An Important Complication of Newer Oral Anticoagulation Agents (2018 · Journal of Clinical Medicine Research · 被引 21)
• Infection Risk of COVID-19 in Dentistry Remains Unknown: A Preliminary Systematic Review (2020 · Infectious Diseases in Clinical Practice · 被引 17)